Jaspreet Kaur Dhillon, FNP

Jaspreet Dhillon practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Jaspreet Dhillon's NPI, 1144861493, was assigned on October 7, 2019. Jaspreet Dhillon holds California license 95012630.

Jaspreet Dhillon's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Jaspreet Dhillon's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Jaspreet Dhillon to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jaspreet Dhillon practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Jaspreet Dhillon's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Jaspreet Dhillon is licensed in California.

Dmand AI lists fluid and electrolyte imbalances, insomnia, tobacco use and UTI among the conditions Jaspreet Dhillon treats.

CMS data shows 792 Medicare services from Jaspreet Dhillon across 7 procedure codes in 2024, for 165 Medicare patients. Medicare paid $34,430 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Jaspreet Dhillon in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have cancer, and 73% have high blood pressure. 24% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jaspreet Dhillon's median patient age at 75, with 14% women.

In 2024, Jaspreet Dhillon wrote 350 Medicare Part D claims for 76 patients. 77% of them were for generic drugs. CMS names the drug for 236 of them, across 13 drugs with 11 or more claims each, at $683,228 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Jaspreet Dhillon for performance year 2024, reported as part of a group.

CMS Open Payments shows 3 general payments to Jaspreet Dhillon from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Daiichi Sankyo Inc. paid the most, $150.